Comparative modeling and docking studies of p16ink4/cyclin D1/Rb pathway genes in lung cancer revealed functionally

Syeda Naqsh e Zahra1, Naureen Aslam Khattak, Asif Mir

  • 1Department of Bioinformatics and Biotechnology, International Islamic University, Islamabad, Pakistan.

Abstract

Insights

This study used computational methods to analyze key lung cancer pathways, identifying specific protein interactions and amino acid targets. These findings could aid in developing new drugs to combat lung cancer.

Area of Science:

  • Computational Biology
  • Molecular Modeling
  • Drug Discovery

Background:

  • Lung cancer is a leading global cause of mortality.
  • Key signaling pathways implicated in lung cancer include growth promotion, inhibition, and apoptosis.
  • In silico strategies were employed to investigate these pathways.

Purpose of the Study:

  • To predict structural models of P16-INK4 and RB1 genes.
  • To explore protein-protein interactions involving P16-INK4 and RB1.
  • To identify potential drug targets within these interactions for lung cancer therapy.

Main Methods:

  • Comparative modeling and molecular docking using YASARA and GRAMM-X servers.
  • Protein-protein interaction analysis via STRING server.
  • Structural quality assessment using WHAT CHECK.

Main Results:

  • Reliable structural models of P16-INK4 and RB1 were predicted.
  • Strong interactions were identified between P16-INK4 and CDK4, and RB1 and E2F1.
  • Specific amino acid residues (Arg47, Arg80, Cys72, Met1 for P16-INK4; Glu864, Ser567, Asp36, Arg861 for RB1) were found to be crucial for these interactions.

Conclusions:

  • The study provides insights into the biological roles of P16-INK4 and RB1 proteins.
  • Identified interacting amino acids can serve as targets for novel drug design.
  • Findings support the development of computer-aided drug design strategies for lung cancer treatment.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...